$BTCS
BTCS Inc. Stock $btcs

$btcs Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223027868 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$316.2K	$385.8K	$514.3K
YoY Change	-8.12%	-25.0%	35.18%
Cost Of Revenue	$83.10K	$113.6K	$93.90K
YoY Change	1.09%	20.99%	58.48%
Gross Profit	$233.1K	$272.1K	$420.4K
YoY Change	-11.01%	-35.27%	30.88%
Gross Profit Margin	73.72%	70.55%	81.74%
Selling, General & Admin	$285.4K	$620.3K	$535.7K
YoY Change	-35.39%	15.78%	70.44%
% of Gross Profit	122.41%	227.93%	127.42%
Research & Development	$148.5K	$180.9K	$185.0K
YoY Change	17.08%	-2.22%	-24.59%
% of Gross Profit	63.71%	66.47%	44.0%
Depreciation & Amortization	$0.00	$1.170K	$930.00
YoY Change	-100.0%	25.81%	933.33%
% of Gross Profit	0.0%	0.43%	0.22%
Operating Expenses	$1.158M	$1.433M	$9.855M
YoY Change	-15.06%	-85.46%	117.51%
Operating Profit	-$925.1K	-$1.161M	-$9.435M
YoY Change	-16.02%	-87.69%	124.12%
Interest Expense	$60.00K	$731.2K	$2.108M
YoY Change	-34.34%	-65.32%	-433.35%
% of Operating Profit
Other Income/Expense, Net	$285.0K	$142.5K	$1.710M
YoY Change	300.0%	-91.67%	-370.35%
Pretax Income	-$640.0K	-$1.018M	-$7.725M
YoY Change	-37.88%	-86.82%	59.53%
Income Tax
% Of Pretax Income
Net Earnings	-$640.1K	-$1.018M	-$7.725M
YoY Change	-37.87%	-86.82%	59.53%
Net Earnings / Revenue	-202.4%	-264.02%	-1501.83%
Basic Earnings Per Share	-$0.04	-$0.07	-$0.61
Diluted Earnings Per Share	-$0.04	-$0.07	-$610.9K
COMMON SHARES
Basic Shares Outstanding	14.33M shares	13.83M shares	12.64M shares
Diluted Shares Outstanding	14.32M shares	13.87M shares	12.64M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$850.0K	$1.043M	$3.211M
YoY Change	-70.58%	-67.51%	-42.3%
Cash & Equivalents	$753.2K	$900.0K	$3.200M
Short-Term Investments	$100.0K	$100.0K
Other Short-Term Assets	$8.050M	$8.361M	$2.737M
YoY Change	184.43%	205.49%	357.54%
Inventory
Prepaid Expenses	$107.4K	$175.4K	$261.2K
Receivables
Other Receivables
Total Short-Term Assets	$8.904M	$9.405M	$5.948M
YoY Change	55.68%	58.11%	-3.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.00K	$8.834K	$10.62K
YoY Change	-2.67%	-16.78%	233.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$5.499M
YoY Change	-100.0%	-100.0%	-33.47%
Total Long-Term Assets	$12.00K	$8.834K	$5.509M
YoY Change	-99.79%	-99.84%	-33.36%
TOTAL ASSETS
Total Short-Term Assets	$8.904M	$9.405M	$5.948M
Total Long-Term Assets	$12.00K	$8.834K	$5.509M
Total Assets	$8.916M	$9.414M	$11.46M
YoY Change	-21.32%	-17.84%	-20.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$90.00K	$188.1K	$139.3K
YoY Change	-10.78%	35.08%	-11.19%
Accrued Expenses	$413.8K	$442.1K	$283.2K
YoY Change	30.45%	56.11%	7575.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$485.1K	$798.4K	$1.067M
YoY Change	-52.89%	-25.17%	-25.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$485.1K	$798.4K	$1.067M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$490.0K	$798.4K	$1.067M
YoY Change	-52.41%	-25.17%	-25.24%
SHAREHOLDERS EQUITY
Retained Earnings	-$154.6M	-$153.9M	-$149.1M
YoY Change	2.98%	3.26%
Common Stock	$14.37K	$160.0M	$159.4M
YoY Change	-99.99%	0.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.431M	$8.615M	$10.39M
YoY Change
Total Liabilities & Shareholders Equity	$8.916M	$9.414M	$11.46M
YoY Change	-21.32%	-17.84%	-20.61%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$640.1K	-$1.018M	-$7.725M
YoY Change	-37.87%	-86.82%	59.53%
Depreciation, Depletion And Amortization	$0.00	$1.170K	$930.00
YoY Change	-100.0%	25.81%	933.33%
Cash From Operating Activities	-$640.0K	-$919.5K	$1.706M
YoY Change	-18.01%	-153.89%	-327.58%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$1.670M	-$620.1K
YoY Change	-107.4%	-369.36%	23.64%
Acquisitions
YoY Change
Other Investing Activities	$280.0K	$1.672M	$0.00
YoY Change	128.44%
Cash From Investing Activities	$270.0K	$2.140K	-$620.0K
YoY Change	-2249.68%	-100.35%	23.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	180.0K	417.7K	-139.9K
YoY Change	-63.32%	-398.52%	-117.49%
NET CHANGE
Cash From Operating Activities	-640.0K	-919.5K	1.706M
Cash From Investing Activities	270.0K	2.140K	-620.0K
Cash From Financing Activities	180.0K	417.7K	-139.9K
Net Change In Cash	-190.0K	-499.6K	946.4K
YoY Change	-37.18%	-152.79%	-309.65%
FREE CASH FLOW
Cash From Operating Activities	-$640.0K	-$919.5K	$1.706M
Capital Expenditures	$10.00K	$1.670M	-$620.1K
Free Cash Flow	-$650.0K	-$2.590M	$2.326M
YoY Change	0.71%	-211.32%	-1036.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		usd
	BTCS	Blockchain Network Fees BlockchainNetworkFees		usd
	BTCS	Sale Of Nonproductive Crypto Assets SaleOfNonproductiveCryptoAssets		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock		usd
	BTCS	Series V Preferred Stock Distribution SeriesVPreferredStockDistribution		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001436229
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	BTCS	Staked Digital Assets Currencies Non Current StakedDigitalAssetsCurrenciesNonCurrent		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders		usd
CY2022Q2	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders		usd
	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40792
	dei	Entity Registrant Name EntityRegistrantName	BTCS Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1096644
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9466 Georgia Avenue #124
	dei	Entity Address City Or Town EntityAddressCityOrTown	Silver Spring
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20910
	dei	City Area Code CityAreaCode	202
	dei	Local Phone Number LocalPhoneNumber	430-6576
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
	dei	Trading Symbol TradingSymbol	BTCS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14333292	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	943418	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2146783	usd
CY2023Q2	BTCS	Crypto Assetscurrencies CryptoAssetscurrencies	948	usd
CY2022Q4	BTCS	Crypto Assetscurrencies CryptoAssetscurrencies	982	usd
CY2023Q2	us-gaap	Investments Investments	100000	usd
CY2022Q4	us-gaap	Investments Investments	100000	usd
CY2023Q2	BTCS	Staked Crypto Assets Currencies StakedCryptoAssetsCurrencies	8185089	usd
CY2022Q4	BTCS	Staked Crypto Assets Currencies StakedCryptoAssetsCurrencies	1826307	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	175395	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	123727	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	9404850	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4197799	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8834	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11152	usd
CY2022Q4	BTCS	Staked Digital Assets Currencies Non Current StakedDigitalAssetsCurrenciesNonCurrent	5708624	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	8834	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5719776	usd
CY2023Q2	us-gaap	Assets Assets	9413684	usd
CY2022Q4	us-gaap	Assets Assets	9917575	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	188144	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	76727	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	253995	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	295935	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	356250	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	798389	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	586412	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14181410	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14181410	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13107149	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13107149	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	14182	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13108	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	159955610	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	160800263	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-153914030	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151482208	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8615295	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9413684	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9917575	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	385753	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	514349	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	697261	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1077364	usd
CY2023Q2	us-gaap	Revenues Revenues	385753	usd
CY2022Q2	us-gaap	Revenues Revenues	514349	usd
	us-gaap	Revenues Revenues	697261	usd
	us-gaap	Revenues Revenues	1077364	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	113612	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	93900	usd
	us-gaap	Cost Of Revenue CostOfRevenue	195626	usd
	us-gaap	Cost Of Revenue CostOfRevenue	231769	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	272141	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	420449	usd
	us-gaap	Gross Profit GrossProfit	501635	usd
	us-gaap	Gross Profit GrossProfit	845595	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	617569	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	512051	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1227398	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1162340	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	180903	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185004	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	382528	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	321722	usd
CY2023Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	578496	usd
CY2022Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	638025	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1040586	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	2061921	usd
CY2023Q2	us-gaap	Marketing Expense MarketingExpense	2723	usd
CY2022Q2	us-gaap	Marketing Expense MarketingExpense	23691	usd
	us-gaap	Marketing Expense MarketingExpense	8966	usd
	us-gaap	Marketing Expense MarketingExpense	65484	usd
CY2023Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	784602	usd
CY2022Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	8894797	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	879509	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	12202225	usd
CY2023Q2	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	731199	usd
CY2022Q2	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	398446	usd
	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	748030	usd
	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	469556	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1433094	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	9855122	usd
	us-gaap	Operating Expenses OperatingExpenses	2790957	usd
	us-gaap	Operating Expenses OperatingExpenses	15344136	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1710000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1068750	usd
	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders	35625	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	142500	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1710000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-142500	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1033125	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1018453	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-7724673	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2431822	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13465416	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13873331	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13873331	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12644719	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12644719	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13773782	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13773782	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12446102	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12446102	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13873331	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13873331	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12644719	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12644719	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13773782	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13773782	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12446102	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12446102	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	926501	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	789453	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2431822	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8615295	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12103443	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10604441	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1782802	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-634557	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13465416	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10390713	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8958194	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	417719	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	257835	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1018453	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8615295	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17531184	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	90674	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	493528	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-7724673	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10390713	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2431822	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13465416	usd
	us-gaap	Depreciation Depreciation	2318	usd
	us-gaap	Depreciation Depreciation	1727	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	789453	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1782802	usd
	BTCS	Validator Revenue ValidatorRevenue	697261	usd
	BTCS	Validator Revenue ValidatorRevenue	1077364	usd
	BTCS	Blockchain Network Fees BlockchainNetworkFees	1321	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1068750	usd
	BTCS	Sale Of Nonproductive Crypto Assets SaleOfNonproductiveCryptoAssets	2547322	usd
	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	748030	usd
	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	469556	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	879509	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	12202225	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	51668	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-63376	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	111417	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	565	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-41940	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	132853	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2045524	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	651105	usd
	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	1804213	usd
	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	9141785	usd
	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	1719871	usd
	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	310149	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2558	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84342	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8834194	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	630801	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	926501	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10604441	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	926501	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9973640	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1203365	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1790551	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2146783	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1400867	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	943418	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3191418	usd
	BTCS	Series V Preferred Stock Distribution SeriesVPreferredStockDistribution	2559533	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zjBTSVMvKU3j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z9CD2zwRaIQ4">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_z8HjvThQ3jRh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zK2Se3rwvc27">Concentration of Cash</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at three financial institutions in checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of six months or less when purchased to be cash and cash equivalents. As of June 30, 2023 and December 31, 2022, the Company had approximately $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20230630_zXDFYk8mm57g" title="Cash and cash equivalents">0.9</span> million and $<span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20221231_z6SzF8qr4D2b" title="Cash and cash equivalents">2.1</span> million in cash. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630__srt--RangeAxis__srt--MaximumMember_zY9PG7bARlZh" title="Cash, FDIC insured amount">250,000</span>. As of June 30, 2023 and December 31, 2022, the Company had approximately $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pn5n6_c20230630_zjN2H88JzsZi" title="Cash, FDIC insured amount">0.3</span> million and $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pn5n6_c20221231_zmkd3swleWUc" title="Cash, FDIC insured amount">1.7</span> million in excess of the FDIC insured limit, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	900000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	300000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1700000	usd
	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	900000	usd
	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	12200000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	700000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	500000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zf1zn5xzswKf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zZ1rCjKqdiN5">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement
	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P2Y9M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1135000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.16
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y9M18D
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1521296	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	20000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	35000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.02
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	11100
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1135000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.16
	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board)
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	635000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	9000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	65000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3478899	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3825035	shares
CY2023Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	356250	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	213750	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1150000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9730	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0372	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0410	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0132	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1590552	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.34
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	50000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	9153	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.37
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1631399	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.25
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	228667	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	508182	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	515221	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1895914	usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	253995	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	295935	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	188144	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	76727	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	442139	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	372662	usd
CY2023Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	254000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	284000	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	95000	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	45000	usd

Files In Submission

Name	View Source	Status
0001493152-23-027868-index-headers.html	Edgar Link	pending
0001493152-23-027868-index.html	Edgar Link	pending
0001493152-23-027868.txt	Edgar Link	pending
0001493152-23-027868-xbrl.zip	Edgar Link	pending
btcs-20230630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
btcs-20230630_cal.xml	Edgar Link	unprocessable
btcs-20230630_def.xml	Edgar Link	unprocessable
btcs-20230630_lab.xml	Edgar Link	unprocessable
btcs-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BTCS
BTCS Inc. Stock $btcs

2023 Q3 Form 10-Q Financial Statement

#000149315223027868 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS BTCS Inc. Stock $btcs

2023 Q3 Form 10-Q Financial Statement

#000149315223027868 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS
BTCS Inc. Stock $btcs